Cost-effectiveness of Extracorporeal Life Support Treatment

• Conditions: Critically Ill

• Registration Number: NCT02837419
• Lead Sponsor: University Medical Center Groningen

Brief Summary

This study evaluates patients on ECLS treatment as considered appropriate with mortality and health related Quality of life and costs.

Detailed Description

A direct comparison between usual care and ECLS treatment is difficult. Alternatively we compare predicted mortality for every patient based on validated scoring systems at the initiation of ECLS treatment with the actual outcome, so every patient is his own control.

Primary outcome is HRQoL assessed with the EQ-5D questionnaire at 1 year. Healthcare costs and costs from a societal perspective are prospectively measured.

Study Timeline

• Study First Submitted: 2016-07-15
• Study First Submitted QC: 2016-07-15
• Study First Posted: 2016-07-19
• Study Start: 2017-12-01
• Status Verified: 2019-09
• Last Update Submitted: 2019-09-24
• Last Update Posted: 2019-09-25
• Primary Completion: 2020-01-01
• Study Completion: 2020-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Admitted to intensive care
• Treated with extracorporeal life support

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
health related quality of life	12 months	health related quality of life with EQ-5D questionnaire at 6 and 12 months

Trial Locations

Locations (1)

University Medical Center Groningen; 🇳🇱 Groningen, Netherlands